SecBot SecBot
8-K ·Filed Apr 15, 2026

TCRT

Alaunos Therapeutics, Inc.
BEARISH
Impact 8/10
Horizonweeks Processed7mo ago SEC0001193125-26-157126
8-K context-dependent: Items 3.01
Actionable Insight ▼ Bearish

Monitor for submission of compliance plan by May 26, 2026; potential reverse split or capital raise could dilute shareholders. Delisting would severely impact liquidity and institutional ownership.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$2.83
T+0 close · Apr 15, 2026 · via day close
Latest settled
−26.36%
T+60 · $2.08
Vs SPY
−33.41%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 16 $2.83entry
  2. T+1 · 7mo ago +3.18%α +1.97% · $2.92
  3. T+5 · 7mo ago −2.47%α −3.46% · $2.76
  4. T+20 · 6mo ago −10.95%α −16.77% · $2.52
  5. T+60 · 4mo ago −26.36%α −33.41% · $2.08
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Alaunos Therapeutics (TCRT) received a delisting notice from Nasdaq due to failing to maintain the $2.5 million minimum stockholders' equity requirement, reporting $2.15 million as of December 31, 2025. The company has 45 days to submit a compliance plan and may request a hearing if needed.

Key Facts

  • Received Nasdaq delisting notice on April 9, 2026, for failing to meet $2.5 million stockholders' equity requirement
  • Reported stockholders' equity of $2,153,000 as of December 31, 2025
  • Does not meet alternative listing standards (market value or net income)
  • Has 45 days (until May 26, 2026) to submit a compliance plan
  • May request a hearing to appeal if plan is rejected

Financial Impact

Stockholders' equity of $2,153,000 vs. required $2,500,000

stockholders equitylisting statusmarket value

Risk Factors

  • Failure to regain compliance could lead to delisting from Nasdaq
  • Reduced investor confidence and liquidity if delisted
  • Potential need for dilutive financing to meet equity requirements

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-157126
Document: 0001193125-26-157126-index-headers.html0001193125-26-157126
Document: 0001193125-26-157126-index.html0001193125-26-157126
Document: 0001193125-26-157126.txt0001193125-26-157126

Track record

14 reports on TCRT

Performance horizon

1 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +23.27% at T+60 after the May 26, 2026 report. 3 of 8 went positive at some point.

Filters
  1. Nov 12, 20264d ago S-3 Bearish 6/10 Entry $1.63 Now $1.60 +1.84% settles Dec 14
  2. Oct 23, 202624d ago 8-K Bullish 5/10 Entry $2.13 Now $1.60 −24.88% settles Nov 23
  3. Oct 21, 202626d ago 8-K Bullish 7/10 Entry $3.04 Now $1.60 −47.37% settles Nov 19
  4. Oct 15, 20264w ago SC 13D/A Neutral 6/10 Entry $2.63 to $1.63 Now $1.60 −39.16% ▼ −38.02% −36.86% vs SPY
  5. Oct 15, 20264w ago SC 13D Neutral 5/10 Entry $2.63 to $1.63 Now $1.60 −39.16% ▼ −38.02% −36.86% vs SPY
  6. Oct 13, 20264w ago Press Release Bullish 8/10 Entry $3.03 to $1.67 Now $1.60 −47.19% ▼ −44.88% −41.21% vs SPY
  7. Oct 13, 20264w ago 8-K Bullish 8/10 Entry $3.03 to $1.71 Now $1.60 −47.19% ▼ −43.56% −39.95% vs SPY
  8. Oct 9, 20265w ago 8-K Bearish 7/10 Entry $1.05 to $1.67 Now $1.60 −52.38% ▼ −59.05% −62.31% vs SPY
  9. Sep 18, 20268w ago Press Release Bearish 5/10 Entry $1.20 to $2.63 Now $1.60 −33.33% ▼ −119.17% −118.96% vs SPY
  10. Sep 16, 20268w ago 8-K Neutral 2/10 Entry $1.60 to $2.18 Now $1.60 +0.00% ▲ +36.25% +34.79% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 5h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 15, 2026